Cargando…
Recurrence of pre‐eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta‐analysis
BACKGROUND: Women with a history of hypertensive disorders, including pre‐eclampsia, during pregnancy have a two‐ to‐five‐fold increased risk of cardiovascular disease (CVD). In 15% of women, pre‐eclampsia recurs in the following pregnancy. OBJECTIVES: To evaluate all evidence on the future risk of...
Autores principales: | Brouwers, L, van der Meiden‐van Roest, AJ, Savelkoul, C, Vogelvang, TE, Lely, AT, Franx, A, van Rijn, BB |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283049/ https://www.ncbi.nlm.nih.gov/pubmed/29978553 http://dx.doi.org/10.1111/1471-0528.15394 |
Ejemplares similares
-
Association of Maternal Prepregnancy Body Mass Index With Placental
Histopathological Characteristics in Uncomplicated Term
Pregnancies
por: Brouwers, Laura, et al.
Publicado: (2018) -
Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when
por: Groenhof, T Katrien J, et al.
Publicado: (2017) -
Clinical pharmacokinetic properties of magnesium sulphate in women with pre‐eclampsia and eclampsia
por: Okusanya, BO, et al.
Publicado: (2015) -
Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic Assessments
por: Zakiyah, Neily, et al.
Publicado: (2015) -
Factors affecting use of magnesium sulphate for pre‐eclampsia or eclampsia: a qualitative evidence synthesis
por: Eddy, KE, et al.
Publicado: (2021)